CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nature Medicine

Topics

Biology

Cancer Oncology

Medicine

Immunology

Internal Medicine

Show all topics

DOI

10.1038/s41591-021-01436-0

License

CC-BY

Other Formats

PDF